Effect of Ayurvedic medicine in Hypothyroidism.

Randomised Controlled Trial To Study The Efficacy of Vasadi Ghanvati In Primary Hypothyroidism with Reference To Kaphaj Pandu. - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/081276

Enrollment

Registered

2025-02-25

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E038- Other specified hypothyroidism

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Cases of Hypothyroidism diagnosed according to classical features , Patients having TSH level between 4 to 20 mIU/L, Patients having T3 (0.8-2.0 ng/mL) and T4 (5.0-12.0 g/dL), Those patients of newly diagnosed with Hypothyroidism

Exclusion criteria

Exclusion criteria: Patients having TSH level greater than 20 mIU/L, Recent thyroid surgery within 12 months, patients on prolonged medications more than 6 weeks with corticosteroid, thyroid replacement therapy, iron supplements, pregnant females and lactating mothers.

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of oral administration of 250 mg Vasadi. Ghan Vati twice a day with madhu for 45 days in management of primary hypothyroidism with reference to Kaphaj panduTimepoint: 15 days	—

Secondary

Measure	Time frame
To study the etiopathogenesis of Kaphaj pandu in detailed according to Ayurveda and hypothyroidism in detail according to modern aspect To study the properties and efficacy of Vasadi Ghan Vati with madhu. To evaluate the effect of Vasadi Ghan Vati with madhu in lowering Sr. TSH. To evaluate the effect of vasadi Ghan Vati with madhu on Sr T3 and T4.Timepoint: 15 days	—

Countries

India

Contacts

Public ContactDr Sandeep Gorakh Mane

Siddhakala ayurved mahavidyalay, sangamner

drsgmane@gmail.com9420014073

Outcome results